Saluda Medical

United States
Quincy, Massachusetts, United States, 55431

Company profile

Saluda Medical company profile

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions using a novel closed-loop, dose-control neuromodulation platform. Its novel neuromodulation platform is designed to sense and measure neural responses to stimulation and automatically adjust therapy based on real-time neurophysiological feedback.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
251-500 employees
Revenue range
$1M-$10M
Founded
2010-01-01, Year

Headquarters

Postal code
55431
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
8
Total equity funding
$529.5M
Last funding
Undisclosed / $30M / 2025-11-12
Last equity funding
Undisclosed / $30M
Investors
10
Lead investors
6
Founders
1
Articles
85
Exited on
2025-12-05

Founders and investors

Founders

John Parker

Lead investors

Action Potential Venture CapitalBioScience Managers LimitedBoston ScientificMedtronicRedmile GroupWellington Management

Investors

Boston ScientificFidelityRedmile GroupTPGWellington Management